Cite
HARVARD Citation
Gangadhar, T. et al. (n.d.). Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States. Journal of immunotherapy. 40 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gangadhar, T. et al. (n.d.). Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States. Journal of immunotherapy. 40 (9), p. . [Online].